6-Methoxy-7-Hydroxyquinazolin-4-One CAS 162012-72-8 Gefitinib Intermediate Purity >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 6-Methoxy-7-Hydroxyquinazolin-4-One (CAS: 162012-72-8) with high quality, intermediate of Gefitinib (CAS: 184475-35-2). Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Gefitinib Intermediates, Please contact: alvin@ruifuchem.com
Chemical Name | 6-Methoxy-7-Hydroxyquinazolin-4-One |
Synonyms | 7-Hydroxy-6-Methoxyquinazolin-4(1H)-One; 7-Hydroxy-6-Methoxy-3,4-Dihydroquinazolin-4-One; 7-Hydroxy-6-Methoxy-3H-Quinazolin-4-One; 7-Hydroxy-6-Methoxy-4(3H)-Quinazolinone; Gefitinib Intermediate 3 |
Stock Status | In Stock, Commercial Production |
CAS Number | 162012-72-8 |
Molecular Formula | C9H8N2O3 |
Molecular Weight | 192.17 g/mol |
Melting Point | >255℃(dec.) |
Density | 1.47±0.10 g/cm3 |
COA & MSDS | Available |
Place of Origin | Shanghai, China |
Product Categories |
Pharmaceutical Intermediates |
Brand | Ruifu Chemical |
Items | Specifications | Results |
Appearance | White to Off-White Solid | White Solid |
Purity / Analysis Method | >98.0% (HPLC Area) | 98.63% |
1H NMR Spectrum | Consistent with Structure | Complies |
Conclusion | The product has been tested and complies with the given specifications |
Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry, well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
6-Methoxy-7-Hydroxyquinazolin-4-One (CAS: 162012-72-8), intermediate of Gefitinib (CAS: 184475-35-2). Gefitinib is an antineoplastic target therapy drug with relatively high specificity that was developed by the British pharmaceutical company AstraZeneca; it is the first molecular targeted drug to be used in non-small cell lung cancer treatment. Epidermal growth factors (EGF) are a kind of polypeptide with a relative molecular mass of 6.45x103, and they can bind with epidermal growth factor receptors (EGFR) on target cell membrane surfaces to trigger biological effects. EGFR is a type of tyrosine kinase (TK) type receptor, so when bound with EGF, it will promote TK activation in the receptor. This will cause tyrosine residue in the receptor to autophosphorylate and send continuous dividing signals into the cell, causing cell proliferation and differentiation. EGFR is abundant in human tissue, and it is highly expressed in malign tumors. Gefitinib blocks the signal transduction pathway of cell surface EGFR to prevent tumor growth, metastasis, and growth in blood vessels, and it can induce tumor cell apoptosis. Gefitinib is mainly used to treat non-stem cell lung cancer.